Posts by: Ana Pena

News

Maintaining high concentrations of Adynovate in the blood of hemophilia A patients decreases the number of bleedings and enables more patients to stop having bleeds, according to the first results ... Read more

January 28, 2019January 28, 2019

Cell-based Gene Therapy May Offer Long-term Treatment for Hemophilia A, Mouse Study Suggests

News

Cell therapy with endothelial progenitor cells and stem cells genetically engineered to produce a functional clotting factor VIII (FVIII) may provide a stable and long-term treatment for hemophilia A, ... Read more

January 11, 2019January 11, 2019

Hepatitis C Virus Is Major Predictor of Liver Cancer in Hemophilia, U.S. Inpatient Data Reveals

News

Past infection with the hepatitis C virus (HCV) is the major risk factor for hepatocellular carcinoma (HCC), the most common type of liver cancer, a large study analyzing more ... Read more

October 12, 2018October 12, 2018

Bypassing Agents Used for Hemophilia A May Also Benefit Children with Hemophilia B, Case Series Reports

News

Single or combination therapy with bypassing agents used for hemophilia A patients with inhibitors can be suitable treatment options for children with hemophilia B with factor IX inhibitors as well, ... Read more

September 14, 2018September 14, 2018

Liver Transplant Highly Benefits, But May Not Fully Cure, Hemophilia, Case Report Shows

News

A liver transplant can be live-saving for hemophilia patients, but may not always fully cure the disease, according to the case report about a hemophilia A patient. The letter ... Read more

July 20, 2018July 20, 2018

BAY 94-9027 Shows Extended Duration in Hemophilia A Patients in Analysis of Trial Data

News

BAY 94‐9027, an investigational factor VIII replacement therapy being developed by Bayer for severe hemophilia A, is able to stay longer in patients’ blood than other standard therapies, according to ... Read more

May 2, 2018May 2, 2018

Gene Therapy Injected Into Dog Muscle Fares Well in Hemophilia B Study

News

Gene therapy delivered to muscle was able to completely correct hemophilia B deficient blood clotting in a safe and well-tolerated manner for several years — in animal models of ... Read more

Posts by: Ana Pena

Ana Pena

Higher Doses of Adynovate is Effective as Preventive Treatment for Hemophilia A, Trial Suggests

Cell-based Gene Therapy May Offer Long-term Treatment for Hemophilia A, Mouse Study Suggests

Hepatitis C Virus Is Major Predictor of Liver Cancer in Hemophilia, U.S. Inpatient Data Reveals

Bypassing Agents Used for Hemophilia A May Also Benefit Children with Hemophilia B, Case Series Reports

Liver Transplant Highly Benefits, But May Not Fully Cure, Hemophilia, Case Report Shows

BAY 94-9027 Shows Extended Duration in Hemophilia A Patients in Analysis of Trial Data

Gene Therapy Injected Into Dog Muscle Fares Well in Hemophilia B Study

Pin It on Pinterest